The World Health Organisation recently classified gaming disorder as a mental health condition for the first time.
News
Novo, Uni of Birmingham team up against fatty liver disease
The partnership aims to identify new disease mechanisms and potential targets for treatment of the disease.
Prokarium secures £4.6m Wellcome funding for Entervax
The funding will be used for a Phase I study in the UK and a Phase Ib age-descending, dose-escalation study in an endemic region in South Asia.
SMC accepts lymphoma, lung cancer treatments in latest meeting
The committee recommended four new medicines and rejected two.
Blood, biopsies could be key to lung cancer spread
Around 47,000 people are diagnosed with lung cancer in the UK each year and fewer than one in five survives for five years or more.
Keytruda to be ‘top drug’ by 2023
The current best selling drug is AbbVie and Eisai’s anti-inflammatory therapy, Himura.
Sensyne, MHRA form research collaboration
The collaboration will contribute to the development of methods to validate software algorithms used in digital health.
MiroBio launches with £27m Series A funding
The fundraising was co-led by Oxford Sciences Innovation and Samsara Biocapital
CMA accuses three drug firms of illegal market sharing
Aspen, Amilco and Tiofarmasigned allegedly signed an illegal agreement that resulted in significant price hikes for fludrocortisone acetate tablets.
UK to lead 500,000 genome sequencing project
The endeavour is the most ambitious genome sequencing project to date, with £50 million in funding from the UK Government’s research and innovation agency.
Microsoft, Silvercloud to “pioneer” AI in mental health
SilverCloud’s digital mental health platform is used across 75% of NHS mental health services and over 250 organisations globally.
Psychiatry Consortium launches novel drug project
Applicants can submit project proposals to the consortium from the 7th of October 2019.
Cognitant, UCB launch interactive healthcare service
The software gives patients access to an interactive explanation of the arthritis disease process.
Servier acquires Pixuvri from CTI BioPharma
The treatment was approved for use in the European Union in June this year.
PIPA releases patient enquiries guidance
The guidance was formed after PIPA found that information provided in response to patient enquiries varied significantly between companies.
